ArticleOncotarget2014

Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation.

Carolina Simioni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.